Is Diphenhydramine + Sodium citrate registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 2 valid registrations of Diphenhydramine + Sodium citrate, including AMYDRAMINE EXPECTORANT SYRUP SUGAR FREE (5.7,1.4 mg/ml,mg/ml, Syrup, SAR 5.15); AMYDRAMINE PAEDIATRIC SYRUP (5.7,1.4 mg/ml,mg/ml, Syrup, SAR 5.15).

Active substances

Diphenhydramine + Sodium citrate

SFDA 2

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
AMYDRAMINE EXPECTORANT SYRUP SUGAR FREE	5.7,1.4 mg/ml,mg/ml	Syrup · Oral use	1 Bottle	SAR 5.15	NCE · OTC	Gulf Pharmaceutical Industries (Julphar)	Valid
AMYDRAMINE PAEDIATRIC SYRUP	5.7,1.4 mg/ml,mg/ml	Syrup · Oral use	1 Bottle	SAR 5.15	Generic · OTC	Gulf Pharmaceutical Industries (Julphar)	Valid

Indications — CHI Daman Drug Formulary

ACUTE COUGH; ALLERGIC CONJUCTIVITIS (AC); BACTERIAL TONSILLOPHARYNGITIS TREATMENT AND PREVENTION; RENAL TRANSPLANT; SCHIZOPHRENIA

Components

Diphenhydramine

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.